Showing 1 - 2 results of 2 for search 'David Bajor', query time: 0.01s Refine Results
  1. 1
    Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab

    Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab by Jared Weiss, Douglas Laux, David Bajor, Albert C. Lockhart, John Hamm, Jeroen Rovers, Alex Karlsson-Parra

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours

    CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours by J. Randolph Hecht, Jean-Marie Michot, David Bajor, Amita Patnaik, Ki Y. Chung, Judy Wang, Gerald Falchook, James M. Cleary, Richard Kim, Anuradha Krishnamurthy, Omkar Marathe, Hagop Youssoufian, Catherine Ellis, Angela Waszak, Srimoyee Ghosh, Hailei Zhang, Kaitlin Yablonski, Shruti D. Shah, Ivan Diaz-Padilla, Susanna Ulahannan

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: